Anúncio
Anúncio
ASND
Ascendis Pharma A/S - ADR
209.34
USDPatrocinado
-1.75
-0.83%
30 de dez., 15:59 UTC -5
Encerrado
Pré-Mercado
208.47
-0.87
-0.42%
Relatórios de Lucros ASND
Rácio de surpresa positiva
ASND separação 16 de 40 últimas estimativas.
40%
Próximo Relatório
Data do Próximo Relatório
10 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$248.11M
/$0.02
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+16.14%
/-102.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+42.66%
/-103.13%
Ascendis Pharma A/S - ADR earnings per share and revenue
On 12 de nov. de 2025, ASND reported earnings of -1.00 USD per share (EPS) for Q3 25, missing the estimate of -0.22 USD, resulting in a -345.63% surprise. Revenue reached 213.63 milhão, compared to an expected 218.08 milhão, with a -2.04% difference. The market reacted with a +3.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of 0.02 USD, with revenue projected to reach 248.11 milhão USD, implying an diminuir of -102.00% EPS, and aumentar of 16.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Ascendis Pharma A/S - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ascendis Pharma A/S - ADR reported EPS of -$1.00, missing estimates by -345.63%, and revenue of $213.63M, -2.04% below expectations.
How did the market react to Ascendis Pharma A/S - ADR's Q3 2025 earnings?
The stock price moved up 3.63%, changed from $199.22 before the earnings release to $206.45 the day after.
When is Ascendis Pharma A/S - ADR expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for Ascendis Pharma A/S - ADR's next earnings report?
Based on 17
analistas, Ascendis Pharma A/S - ADR is expected to report EPS of $0.02 and revenue of $248.11M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio